MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
HLN stock logo

HLN

Haleon plc

$9.93
-0.04
 (-0.4%)
Exchange:  NYSE
Market Cap:  44.274B
Shares Outstanding:  9.235B
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Drug Manufacturers – Specialty & Generic
   
CEO:  Brian James McNamara
Full Time Employees:  24561
Address: 
Building 5
Weybridge
KT13 0NY
GB
Website:  https://www.haleon.com
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

Click to read more…

Revenue Segmentation

MARKETSnap
MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2025/05/02 — Q1 quarter 2025

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue11,302,00011,233,00010,788,282.358
Gross Profit6,961,0006,948,0006,987,442.354
EBITDA2,351,0002,514,0002,772,872.209
Operating Income1,996,0002,206,0002,420,761.453
Net Income1,049,0001,442,0001,630,468.421

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets34,055,00034,315,00032,572,646.510
Total Liabilities17,326,00018,091,00016,117,620.304
Total Stockholders Equity16,606,00016,166,00016,396,129.908
Total Debt9,456,00010,102,0008,593,868.029
Cash and Cash Equivalents1,044,0002,195,0001,321,672.815

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow2,100,0002,301,0002,285,785.663
Capital Expenditure-336,000-250,000-314,943.506
Free Cash Flow1,764,0002,051,0001,970,842.156
Net Income1,111,0001,442,0001,630,468.421
Net Change in Cash383,0001,213,000-769,659.848

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)13,425,233.255Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)13,796,992.404Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)13,580,586.994Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)3,918,541.893Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)4,027,050.533Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)3,963,886.367Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)2,512,314.196Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)2,603,101.734Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)2,550,251.222Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)5,179,622.432Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)5,323,051.748Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)5,239,559.842Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)0.570Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)0.580Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)0.560Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)13Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
14.354B  ?P/S
 (TTM)
: 
3.88
?Net Income
 (TTM)
: 
1.843B  ?P/E
 (TTM)
: 
31.32
?Enterprise Value
 (TTM)
: 
39.225B  ?EV/FCF
 (TTM)
: 
42.13
?Dividend Yield
 (TTM)
: 
0.02  ?Payout Ratio
 (TTM)
: 
0.4
?ROE
 (TTM)
: 
0.06  ?ROIC
 (TTM)
: 
0.04
?Net Debt
 (TTM)
: 
9.865B  ?Debt/Equity
 (TTM)
: 
0.52
?P/B
 (TTM)
: 
1.98  ?Current Ratio
 (TTM)
: 
0.92

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
17.41Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

Strengths (preview)
  • Strong Emerging Market Performance: Haleon demonstrated robust momentum in emerging markets during the Full Year 2024 Earnings Call, contributing significantly to overall revenue growth. This highlights the company’s effective market penetration and brand strength in high-growth regions.
  • Positive Financial Metrics: Key financial results from the 2024 earnings call and income statements indicate consistent revenue and gross profit growth, supported by strategic product innovations. The company’s operating cash flow and free cash flow remain solid, reflecting operational efficiency.
  • Innovation-Driven Growth: The earnings call emphasized Haleon’s focus on product innovation as a key driver of performance, positioning the company to maintain competitive advantage within its industry.
  • Favorable Valuation Metrics: Haleon’s current price-to-earnings ratio (P/E TTM) and forward P/E ratios suggest the stock is reasonably valued compared to industry averages, offering potential stability for investors based on analyst estimates.

Log in with Full Access for Weaknesses, Opportunities, Threats, and the complete SWOT.

Log in to continue

Log in with Full Access for the complete SWOT analysis.

Login — it's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate HLN Intrinsic Value

Common questions about HLN valuation

Is Haleon plc (HLN) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Haleon plc (HLN) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is HLN a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether HLN trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is HLN’s P/E ratio?

You can see HLN’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for HLN?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is HLN a good long-term investment?

Whether HLN fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

HLN

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-0.4
MARKETSnap

Trading Metrics:

Open: 9.91   Previous Close: 9.97
Day Low: 9.87   Day High: 10
Year Low: 8.71   Year High: 11.42
Price Avg 50: 10.49   Price Avg 200: 9.87
Volume: 4.486M   Average Volume: 8.321M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free

HLN full analysis

12/03/2026

Hey everyone, welcome back to the channel! Today, we’re diving deep into a comprehensive analysis of Haleon, ticker HLN, a major player in the consumer healthcare space. If you’re curious about whether this stock deserves a spot in your portfolio, stick around because we’re breaking down everything from financials to recent performance, and even a SWOT analysis to give you the full picture. Let’s get started! First off, let’s set the stage. Haleon is a company that’s all about everyday…

Listen to full analysis (audio file)

Open in MarketSnap Listen

Log in to continue

Log in to see the full analysis preview and audio links.

Login — it's free

See in Nexus

Relevant news

NEW parodontax Gum Strengthen & Protect Launches as a Daily Solution for Long-Term Gum Protection
12-03-2026 09:00
NEW parodontax Gum Strengthen & Protect Launches as a Daily Solution for Long-Term Gum Protection
Haleon Strengthens Commitment to China as Consumers Focus on Better Everyday Health
11-03-2026 05:00
Haleon makes oral-health push in China as other Western brands falter
Study in Nature Medicine Finds Taking Centrum Silver Daily May Slow Biological Aging
Haleon PLC Sponsored ADR (HLN) Moves to Buy: Rationale Behind the Upgrade
Haleon's weaker sales make mid-term targets 'not look credible'

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read